Navigation Links
Better Communication With FDA Could Speed Up Approval Of New Drugs

A new report commissioned by the Food and Drug Administration has found that newer medicines could hit the markets sooner if regulators met with the drug makers and apprised them of their concerns regarding that particular// medication before it went into the final phase of human testing.

The report by consulting firm Booz Allen Hamilton, on behalf of the FDA said that 53 percent of drug makers who met with the FDA before conducting trials had their applications approved out of a total of 77 applications received between 2002 to 2004.Compared to this only 29 percent of drug makers who did not meet up with the FDA had their medicines approved. "We have seen a pretty dramatic growth in the number of meetings we're having with sponsors in the past several years. Any additional workload for meetings is going to have to be supported by additional staffing," said Dr. John Jenkins, director of the FDA's Office of New Drugs. He added that the FDA would discuss this issue in the next meeting and would also take a note of the fees paid for such reviews. The report added that many drugs that failed to clear the first cycle were deficient in only a couple of areas and that had the FDA voiced these concerns, the companies would have been able to fix them. "Early and open communication with the sponsors will allow sponsors to address/resolve issues in a timely manner, potentially within the first review cycle," the report stressed. Dr Jenkins admitted that the communications segment of the FDA had room for improvement, but "some of the burden relies on the sponsors to make sure they understand what is being told." The report also noted that smaller companies had a tough time getting regulatory approval for their products, "Large, U.S.-based companies have the highest first-cycle approval rate, at approximately twice the rate of small biotechnology companies with no prior FDA approvals," it concluded.
'"/>




Page: 1

Related medicine news :

1. Better prostate cancer detection
2. Better Treatment for obesity
3. For a Better Memory
4. Baby Talk Better Than Adult Speech
5. Drug Combo Works Better for children with ADHD, Tics
6. Better skin with lasers
7. Better diabetes treatment promises Vanadium
8. Better Prostate Cancer Test
9. Better Drug for Heart Transplant
10. Better Diet Even Late in Life May Prolong It
11. Better Care Required for Breast Cancer Survivors
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/27/2017)... ... 27, 2017 , ... From May 21-23, hearing healthcare professionals gained a competitive ... at the Marriott Syracuse Downtown Hotel in Syracuse, New York. , As EarQ’s ... hearing healthcare providers to help them stay ahead in the industry. At the event, ...
(Date:5/26/2017)... ... May 26, 2017 , ... Leading CEOs from biotech, ... 30th and 31st at The Four Seasons Hotel Boston. , The Boston ... sciences, offering exclusive access to key decision makers who influence deal making and ...
(Date:5/26/2017)... ... May 26, 2017 , ... A new analysis of ... the healthiest seniors are located in the Midwest. With the average cost of healthcare ... people are concerned with both the quality and affordability of where they live. An ...
(Date:5/26/2017)... ... ... After raising nearly $30,000 on Kickstarter , about three-times its original ... discounted crowdfunding price on Indiegogo . , “Along with creating an anti-stress gadget ... a fidget toy to the market that was made of superior quality and wouldn’t ...
(Date:5/26/2017)... ... May 26, 2017 , ... Dr. Alex Rabinovich, a highly-skilled ... a new, informational blog post on insurance options. If a Bay Area patient has ... help save time and money. Visiting an in-network provider for a second opinion can ...
Breaking Medicine News(10 mins):
(Date:5/22/2017)... N.Y. , May 22, 2017  Lilac ... treatment Gene-Eden-VIR/Novirin, announces the launch of a ... English, the results of a clinical study that ... year treatment with Gene-Eden-VIR/Novirin in individuals suffering from ... to note that there are no other treatments ...
(Date:5/15/2017)... , May 15, 2017  Amy Baxter MD, ... industry leader in noninvasive pain relief, was awarded a ... magazine. Baxter was recognized at the MM&M Top ... New York City on May 10, 2017. ... the biopharma industry go "beyond the pill."  ...
(Date:5/10/2017)... May 10, 2017 Hologic, Inc. (Nasdaq: ... for the fiscal second quarter ended April 1, 2017 ... $1.84 increased 666.7% compared to the prior year period ... in a significant gain, while non-GAAP diluted EPS of ... or 3.8% in constant currency terms.  Excluding the effects ...
Breaking Medicine Technology: